1. Home
  2. NTRA vs CFG Comparison

NTRA vs CFG Comparison

Compare NTRA & CFG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTRA
  • CFG
  • Stock Information
  • Founded
  • NTRA 2003
  • CFG 1828
  • Country
  • NTRA United States
  • CFG United States
  • Employees
  • NTRA N/A
  • CFG N/A
  • Industry
  • NTRA Medical Specialities
  • CFG Major Banks
  • Sector
  • NTRA Health Care
  • CFG Finance
  • Exchange
  • NTRA Nasdaq
  • CFG Nasdaq
  • Market Cap
  • NTRA 18.4B
  • CFG 21.3B
  • IPO Year
  • NTRA 2015
  • CFG 2014
  • Fundamental
  • Price
  • NTRA $148.08
  • CFG $35.45
  • Analyst Decision
  • NTRA Strong Buy
  • CFG Buy
  • Analyst Count
  • NTRA 17
  • CFG 19
  • Target Price
  • NTRA $176.65
  • CFG $46.32
  • AVG Volume (30 Days)
  • NTRA 1.6M
  • CFG 6.6M
  • Earning Date
  • NTRA 05-08-2025
  • CFG 04-16-2025
  • Dividend Yield
  • NTRA N/A
  • CFG 4.74%
  • EPS Growth
  • NTRA N/A
  • CFG 13.68
  • EPS
  • NTRA N/A
  • CFG 3.15
  • Revenue
  • NTRA $1,696,911,000.00
  • CFG $7,116,000,000.00
  • Revenue This Year
  • NTRA $15.33
  • CFG $15.85
  • Revenue Next Year
  • NTRA $18.50
  • CFG $8.50
  • P/E Ratio
  • NTRA N/A
  • CFG $11.24
  • Revenue Growth
  • NTRA 56.75
  • CFG N/A
  • 52 Week Low
  • NTRA $83.13
  • CFG $32.60
  • 52 Week High
  • NTRA $183.00
  • CFG $49.25
  • Technical
  • Relative Strength Index (RSI)
  • NTRA 50.83
  • CFG 38.18
  • Support Level
  • NTRA $125.38
  • CFG $34.88
  • Resistance Level
  • NTRA $152.66
  • CFG $36.62
  • Average True Range (ATR)
  • NTRA 8.82
  • CFG 2.12
  • MACD
  • NTRA 1.47
  • CFG -0.03
  • Stochastic Oscillator
  • NTRA 82.19
  • CFG 31.39

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

About CFG Citizens Financial Group Inc.

Citizens Financial Group is a bank holding company headquartered in Providence, Rhode Island. Its two primary business segments are consumer banking and commercial banking. Citizens offers a mix of retail and commercial products including capital markets and wealth options. The bank has over 1,100 branches in 14 states, although it is concentrated in the Northeast. It has over $220 billion of total assets. It generates maximum revenue from Consumer Banking Segment.

Share on Social Networks: